NATHANIEL A KHO
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology DALLAS, TX NPI 1689757189
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology TX UCB, Inc. All categories
General Payments — all program years on this page
$8,662.35
- Category: General Payments
- Program years: PY2018–2024
- Record count: 300
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $257.53 across 10 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $257.53 | 10 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $95.88 | 4 |
| ABBVIE INC. | $86.09 | 2 |
| ACADIA Pharmaceuticals Inc | $22.34 | 1 |
| ARGENX US, INC. | $21.09 | 1 |
| SK Life Science, Inc. | $18.20 | 1 |
| LivaNova USA, Inc. | $13.93 | 1 |
By program year
Records — PY2024 (10)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104065806 | ABBVIE INC. | $72.19 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104065808 | ABBVIE INC. | $13.90 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142103645 | ARGENX US, INC. | $21.09 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143484412 | UCB, Inc. | $18.54 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143484419 | UCB, Inc. | $28.86 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143484425 | UCB, Inc. | $22.68 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143484432 | UCB, Inc. | $25.80 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147980291 | ACADIA Pharmaceuticals Inc | $22.34 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152796979 | LivaNova USA, Inc. | $13.93 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154120915 | SK Life Science, Inc. | $18.20 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.